Skip to main navigation Skip to search Skip to main content

Economic Costs Associated with Atrial Fibrillation

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

As the population ages, the incidence and prevalence of atrial fibrillation (AF) is expected to increase, resulting in significant societal and economic impact. By 2050, AF is projected to affect 15.9 million individuals in the United States. Atrial fibrillation results in a variety of adverse outcomes, including a fivefold increased risk of stroke, impaired quality of life, decreased work productivity, and increased rates of hospitalization. In 2005, there were 470,000 U.S. hospitalizations secondary to AF. In 2004, over 9 million working days were lost because of AF. Costs of AF and its associated complications are enormous. In 2006, costs attributable to AF-associated stroke equaled $12 billion. In addition, $41,000 to $105,000 per patient was spent on aggregate and individual AF care. Because of its increasing prevalence, numerous complications, and large costs, AF presents a significant challenge for patients, clinicians, and health care policymakers. Finding strategies to best care for these patients will become increasingly important.

Original languageEnglish
Title of host publicationContemporary Cardiology
PublisherSpringer International Publishing
Pages13-26
Number of pages14
DOIs
StatePublished - 2008

Publication series

NameContemporary Cardiology
VolumePart F10917
ISSN (Print)2196-8969
ISSN (Electronic)2196-8977

Keywords

  • AF cost
  • AF hospitalizations
  • Incidence of AF
  • Prevalence of AF
  • Stroke

Fingerprint

Dive into the research topics of 'Economic Costs Associated with Atrial Fibrillation'. Together they form a unique fingerprint.

Cite this